Company Name: Global Blood Therapeutics Inc.   

Global Blood Therapeutics Inc. is a clinical-stage biopharmaceutical company.  The company is engaged in the development of therapeutics designed to treat blood-based disorders.  The company’s lead product candidate is a therapy designed to treat sickle cell disease.

Ticker Symbol: GBT (NASDAQ)

Company Website:

Social Media: Global Blood Therapeutics LinkedIn

Headquarters: South San Francisco, CA